BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

SRS Capital Advisors, Inc.'s Holding History (CIK: 0001586767)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 46 Value ($000) $0 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 2,993 Value ($000) $23 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 703 Value ($000) $6 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 1,111 Value ($000) $8 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 738 Value ($000) $6 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 738 Value ($000) $6 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 778 Value ($000) $5 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 84 Value ($000) $0 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 52 Value ($000) $0 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 52 Value ($000) $0 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 52 Value ($000) $0 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 51 Value ($000) $0 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 38 Value ($000) $0 Avg Close $12.47 Range $10.36 - $14.50